AbCellera Biologics Inc.ABCLEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| Carl L.G. Hansen | 20.60% | 60.7M | — | 2024-02-13 |
| Baker Bros. Advisors LP | 9.30% | 27.5M | ▲ +1.40pp | 2024-11-14 |
| Nos. of above persons | 8.29% | 24.0M | — | 2024-01-29 |
| Peter Thiel | 4.99% | 14.4M | — | 2023-04-24 |
Insider Transactions
Net 90d: +$856.7K · buys $856.7K / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-02-27 | Thermopylae Holdings Ltd. | 10% Owner | Buy (open market) | 38.0K | $3.44 | $130.7K |
| 2026-02-27 | Andrew Booth | Chief Financial Officer | Buy (open market) | 42.6K | $3.42 | $145.7K |
| 2026-02-26 | Thermopylae Holdings Ltd. | 10% Owner | Buy (open market) | 177.5K | $3.27 | $580.3K |
1–3 of 3